GoHealth (GOCO) Cash from Financing Activities (2020 - 2026)

GoHealth's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$25000.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 99.22% year-over-year to -$25000.0; the TTM figure through Mar 2026 stood at $125.2 million (up 465.06% YoY), while the FY2025 annual figure was $122.0 million, up 480.84% from the prior year.
• Cash from Financing Activities came in at -$25000.0 for Q1 2026 at GoHealth, down from $39.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $53.9 million in Q2 2025 to a low of -$156.6 million in Q4 2022.
• A 5-year average of -$2.7 million and a median of -$1.4 million in 2022 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities slumped 1036.16% in 2023 and jumped 1026.9% in 2024, its largest moves.
• GoHealth's Cash from Financing Activities stood at -$156.6 million in 2022, then soared by 99.31% to -$1.1 million in 2023, then sank by 541.12% to -$7.0 million in 2024, then soared by 672.66% to $39.9 million in 2025, then plunged by 100.06% to -$25000.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$25000.0, $39.9 million, and $31.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison